StroCare - Optimised Cross-sectoral,Coordinated Treatment of Stroke Patients With Patient-orientated Outcome Measurement
NCT04159324 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 409
Last updated 2023-12-29
Summary
The Trial is a multi-centred controlled interventional study with a pre-post design. The primary aim of the study is the evaluation of the effectiveness and cost-effectiveness of the StroCare treatment.
Conditions
Interventions
- OTHER
-
optimized cross-sectoral, structured and coordinated treatment pathway that integrates a patient-centred outcome evaluation
the optimized treatment pathway includes coordinated transitions between rehabilitation phases and institutes using individual case management and portal solutions
Sponsors & Collaborators
-
Albertinen Krankenhaus
collaborator OTHER -
Elbe Kliniken Stade-Buxtehude GmbH
collaborator UNKNOWN -
Reha Centrum Hamburg GmbH
collaborator UNKNOWN -
Klinikum Bad Bramstedt GmbH
collaborator UNKNOWN -
MediClin Klinikum Soltau GmbH
collaborator UNKNOWN -
VAMED Klinik Geesthacht
collaborator UNKNOWN -
VAMED Rehaklinik Damp
collaborator UNKNOWN -
BARMER Krankenkasse
collaborator UNKNOWN -
Lohmann und Birkner medizinisches ServiceCenter GmbH
collaborator UNKNOWN -
Forcare GmbH
collaborator OTHER -
Universitätsklinikum Hamburg-Eppendorf
lead OTHER
Principal Investigators
-
Götz Thomalla, Prof. Dr. · University Medical Centre Hamburg-Eppendorf
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- SEQUENTIAL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-01-01
- Primary Completion
- 2023-12-05
- Completion
- 2023-12-05
Countries
- Germany
Study Locations
More Related Trials
-
Donepezil Trial for Motor Recovery in Acute Stroke
NCT01442766 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Reparative Therapy in Acute Ischemic Stroke With Allogenic Mesenchymal Stem Cells From Adipose Tissue, Safety Assessment, a Randomised, Double Blind Placebo Controlled Single Center Pilot Clinical Trial
NCT01678534 ·Status: COMPLETED ·Phase: PHASE2
-
STROKE 120 ACTION Trial
NCT07135310 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The Androtriol Injection for the Treatment of Acute Ischemic Stroke
NCT06679322 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Promoting Recovery After STroke With Amantadine
NCT05140148 ·Status: RECRUITING ·Phase: PHASE2
-
Electronic Monitoring and Improvement of Adherence to DOACs in Polymedicated Stroke Patients
NCT03344146 ·Status: COMPLETED ·Phase: NA
-
Transitional Care Program to Improve Risk Factors in Stroke Survivors
NCT06657235 ·Status: RECRUITING ·Phase: NA
-
A Proof of Concept Study to Evaluate the Safety of Afamelanotide in Patients With Acute Arterial Ischaemic Stroke (AIS)
NCT04962503 ·Status: COMPLETED ·Phase: PHASE2
-
Stroke Ready - Optimizing Acute Stroke Care
NCT03645590 ·Status: COMPLETED ·Phase: NA
-
IMPROVE Stroke Care- Developing and Optimizing Regional Systems of Stroke Care
NCT04242784 ·Status: COMPLETED
-
Efficacy and Safety of MRI-based Thrombolysis in Wake-up Stroke
NCT01525290 ·Status: COMPLETED ·Phase: PHASE3
-
Secondary Prevention of Stroke Through Non-drug Therapeutic Weight Reduction
NCT01721538 ·Status: UNKNOWN ·Phase: NA
-
"Mobile Stroke Unit"-Concept for Delivery of Specialized Acute Stroke Care to Patients in Remote Areas
NCT02465346 ·Status: COMPLETED ·Phase: NA
-
Stroke Card Long-term Follow-Up
NCT04205006 ·Status: UNKNOWN
-
Allogeneic Adipose Tissue-derived Mesenchymal Stem Cells in Ischemic Stroke
NCT04280003 ·Status: UNKNOWN ·Phase: PHASE2
-
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
NCT02448641 ·Status: COMPLETED ·Phase: PHASE2
-
Pilot Investigation of Stem Cells in Stroke
NCT01151124 ·Status: COMPLETED ·Phase: PHASE1
-
Randomized a Clinical Trial With Medical Device in Acute Ischemic Stroke
NCT07113184 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Study to Evaluate the Safety and Potential Efficacy of LT3001 Drug Product in Subjects With AIS
NCT04091945 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safety of CP-101,606 in Subjects With an Acute Stroke
NCT00073476 ·Status: TERMINATED ·Phase: PHASE2
-
Neuroprotection With Statin Therapy for Acute Recovery Trial Phase 2
NCT01976936 ·Status: COMPLETED ·Phase: PHASE2
-
Beta Blockers In Acute Ischemic Stroke
NCT01061190 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The Efficacy and Safety of MK0724 IV for Improvement of Neurological Damage and Recovery From Middle Cerebral Artery Ischemic Stroke (0724-018)
NCT00401310 ·Status: TERMINATED ·Phase: PHASE2
-
Identification of Biomarkers in Ischemic Stroke - Clinical Trial
NCT04253275 ·Status: COMPLETED ·Phase: NA
-
THrombolysis for Acute Wake-up and Unclear-onset Strokes With Alteplase at 0.6 mg/kg Trial (THAWS)
NCT02002325 ·Status: UNKNOWN ·Phase: PHASE3